Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Corticostriatal network dysfunction in Huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release
George V. Rebec
CNS Neuroscience & Therapeutics (2018) Vol. 24, Iss. 4, pp. 281-291
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Cortical and Striatal Circuits in Huntington’s Disease
Sonja Blumenstock, Irina Dudanova
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 90
Dysfunction of the corticostriatal pathway in autism spectrum disorders
Wei Li, Lucas Pozzo‐Miller
Journal of Neuroscience Research (2019) Vol. 98, Iss. 11, pp. 2130-2147
Open Access | Times Cited: 86
Neurobiology of vitamin C: Expanding the focus from antioxidant to endogenous neuromodulator
Santiago Ballaz, George V. Rebec
Pharmacological Research (2019) Vol. 146, pp. 104321-104321
Closed Access | Times Cited: 83
Molecular Pathophysiological Mechanisms in Huntington’s Disease
Anamaria Jurcău
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1432-1432
Open Access | Times Cited: 61
Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases
Thomas McGrath, Richard Baskerville, Marcelo Macedo Rogero, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 917-917
Open Access | Times Cited: 56
Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models
Jordi Creus‐Muncunill, Michelle E. Ehrlich
Neurotherapeutics (2019) Vol. 16, Iss. 4, pp. 957-978
Open Access | Times Cited: 43
Neuroadaptation in neurodegenerative diseases: compensatory mechanisms and therapeutic approaches
Spandana Rajendra Kopalli, Tapan Behl, Lalji Baldaniya, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111375-111375
Closed Access
Treadmill exercise rescues mitochondrial function and motor behavior in the CAG140 knock-in mouse model of Huntington's disease
Charles C. Caldwell, Giselle M. Petzinger, Michael W. Jakowec, et al.
Chemico-Biological Interactions (2019) Vol. 315, pp. 108907-108907
Open Access | Times Cited: 30
D1R- and D2R-Medium-Sized Spiny Neurons Diversity: Insights Into Striatal Vulnerability to Huntington’s Disease Mutation
Guendalina Bergonzoni, Jessica Döring, Marta Biagioli
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 24
The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington’s disease
J. Pérot, Emmanuel Brouillet, Julien Flament
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 3
Huntington's disease: From basic science to therapeutics
Carlos Cepeda, Xiaoping Tong
CNS Neuroscience & Therapeutics (2018) Vol. 24, Iss. 4, pp. 247-249
Open Access | Times Cited: 29
The Tiny Drosophila Melanogaster for the Biggest Answers in Huntington’s Disease
Abraham Rosas‐Arellano, Argel Estrada‐Mondragón, Ricardo Piña, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2398-2398
Open Access | Times Cited: 28
Tailoring Oxygen-Containing Groups on Graphene for Ratiometric Electrochemical Measurements of Ascorbic Acid in Living Subacute Parkinson’s Disease Mouse Brains
Zhibei Qu, Yimin Jiang, Jiaxin Zhang, et al.
Analytical Chemistry (2021) Vol. 93, Iss. 49, pp. 16598-16607
Closed Access | Times Cited: 21
Longitudinal multimodal MRI characterization of a knock-in mouse model of Huntington’s disease reveals early gray and white matter alterations
J. Pérot, Marina Célestine, Marco Palombo, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. 21, pp. 3581-3596
Open Access | Times Cited: 14
Dysregulation of the Basal Ganglia Indirect Pathway in Early SymptomaticQ175Huntington's Disease Mice
Joshua W. Callahan, David L. Wokosin, Mark D. Bevan
Journal of Neuroscience (2022) Vol. 42, Iss. 10, pp. 2080-2102
Open Access | Times Cited: 13
Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1α Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2
María E. Prados, Alejandro Correa-Sáez, Juan D. Unciti‐Broceta, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 3, pp. 1849-1861
Open Access | Times Cited: 17
Cerebrolysin restores balance between excitatory and inhibitory amino acids in brain following concussive head injury. Superior neuroprotective effects of TiO2 nanowired drug delivery
Hari Shanker Sharma, Dafin F. Mureşanu, Seaab Sahib, et al.
Progress in brain research (2021), pp. e5-e6
Closed Access | Times Cited: 15
HSF1 and Its Role in Huntington’s Disease Pathology
Hyuck Kim, Rocío Gómez‐Pastor
Advances in experimental medicine and biology (2022), pp. 35-95
Closed Access | Times Cited: 9
Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity
Susanne Nikolaus, Hans‐Jörg Wittsack, Markus Beu, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 179, pp. 156-170
Closed Access | Times Cited: 15
Acute lysine overload provokes marked striatum injury involving oxidative stress signaling pathways in glutaryl-CoA dehydrogenase deficient mice
Alexandre Umpierrez Amaral, Bianca Seminotti, Janaína Camacho da Silva, et al.
Neurochemistry International (2019) Vol. 129, pp. 104467-104467
Closed Access | Times Cited: 11
Regional Differences in Dopamine Release in the R6/2 Mouse Caudate Putamen
Sam V. Kaplan, Ryan Limbocker, Beth Levant, et al.
Electroanalysis (2018) Vol. 30, Iss. 6, pp. 1066-1072
Open Access | Times Cited: 7
The Ties That Bind: Aberrant Plasticity and Networks Dysfunction in Movement Disorders—Implications for Rehabilitation
Davide Ferrazzoli, Paola Ortelli, Daniele Volpe, et al.
Brain Connectivity (2021) Vol. 11, Iss. 4, pp. 278-296
Closed Access | Times Cited: 6
A Review of Glutamate and Its Receptors: Their Roles in Brain Physiology and Pathology
Sevgi Uğur Mutluay, Hülya Karataş
Acta Medica (2022) Vol. 53, Iss. 2, pp. 99-109
Open Access | Times Cited: 4
Analysis of Synaptic Glutamate Clearance as a Possible Indicator of Synaptic Health in the Degenerating Rodent Brain
Anton Dvorzhak, Rosemarie Grantyn
Neuromethods (2024), pp. 207-227
Closed Access
Page 1 - Next Page

Scroll to top